Savings From the EpiPen Authorized Generic: A Retrospective Analysis of Medicaid Data

Journal of General Internal Medicine - Germany
doi 10.1007/s11606-019-04989-6
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Managed Medicaid Cost Savings: The Arizona Experience

Health Affairs
MedicineHealth Policy
1994English

Potential Savings From Greater Use of $4 Generic Drugs

Archives of Internal Medicine
2011English

CGM Retrospective Data Analysis

Diabetes Technology and Therapeutics
MedicineEndocrinologyMedical Laboratory TechnologyMetabolismDiabetes
2016English

Children With Medical Complexity and Medicaid: Spending and Cost Savings

Health Affairs
MedicineHealth Policy
2014English

The Effects of State Medicaid Policies on the Dynamic Savings Patterns of the Elderly

2006English

Health Care Utilization Among Medicare-Medicaid Dual Eligibles: A Count Data Analysis

BMC Public Health
EnvironmentalPublic HealthOccupational Health
2006English

Retrospective Analysis of the Economic Burden of Patients Diagnosed With Congestive Heart Failure in the California Medicaid Population

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

Potential Unintended Pregnancies Averted and Cost Savings Associated With a Revised Medicaid Sterilization Policy

Contraception
GynecologyReproductive MedicineObstetrics
2013English

State Generic Substitution Laws Can Lower Drug Outlays Under Medicaid

Health Affairs
MedicineHealth Policy
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy